SeanCollinsMD
Emergency Medicine • Nashville, TNProfessor and Executive Vice Chair, Emergency Medicine, Vanderbilt University School of Medicine
Dr. Collins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1313 21st Ave S
Nashville, TN 37232Phone+1 615-875-6151Fax+1 615-936-3754
Education & Training
University of Cincinnati Medical Center/College of MedicineResidency, Emergency Medicine, 1997 - 2001
University of Wisconsin School of Medicine & Public HealthClass of 1997
Certifications & Licensure
TN State Medical License 2011 - 2026
OH State Medical License 1998 - 2013
KY State Medical License 2000 - 2012
American Board of Emergency Medicine Emergency Medicine
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Clinical Trials
- Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure Start of enrollment: 2012 Jul 01
- Fluid Status of Outpatients With Dyspnea Start of enrollment: 2014 Jun 01
- A Randomized Trial of Telemetry Compared With Unmonitored Floor Admissions in ED Patients With Low-Risk Chest Pain Start of enrollment: 2020 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Modulation of the renin-angiotensin system against COVID-19: A path forward?Serge Camelo, Waly Dioh, J Pedro Teixeira, Laurence W Busse, Girish Nair
International Journal of Infectious Diseases. 2025-03-04 - Wet and Sent Home From Heart Failure Hospitalization.Sean P Collins, Hasan K Siddiqi, Lynne Warner Stevenson
JACC. Heart Failure. 2025-03-01 - 1 citationsPrognostic Implications and Global Perspectives of Atrial Fibrillation in Patients Hospitalized for Heart Failure.Janice Y Chyou, Wan Ting Tay, Jasper Tromp, Wouter Ouwerkerk, Kai Hang Yiu
JACC. Heart Failure. 2025-03-01
Press Mentions
Immune-Suppressing Drug Does Not Improve COVID-19 Recovery: StudyDecember 17th, 2024- Fostamatinib Fails to Improve Outcomes in Hypoxemic COVID PatientsDecember 6th, 2024
- ITP Drug Disappoints in Hospitalized COVID Patients with HypoxemiaDecember 4th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
